SPL

2.08%

9.8¢ starpharma holdings limited

Why not an Aztrazenica buyout, page-2

First 2 Last

Share
Profile

Follow
mukesh2001

752 Posts.

26/03/17

17:30

Post #: 23633253
Share

Originally posted by thrasher ↑

I don't understand why some are cynical about an AZ buyout, as shown below link only couple of days ago they state they are looking for potentials to acquire and increasing partnerships with a view to increasing their pipeline, why not Starpharma they already have three candidates moving towards the pipeline Starpharma would give then DEP?dox entering phase 11 another 2 or 3 that Starpharma have done pre-clinicals on and the opportunity to use the platform on multiple drugs now shelved or needing new patents. They could get double figure drugs into the pipeline fairly easily, did Jackie not say that AZ results were excellent and the platform is showing vastly improved results on current drugs. AZ would also get the BV cream almost ready for FDA approvel and already approved in Europe and therefore much of the world, as far as condoms and Agro they could sell off if they did not want, the dendrimer also has potential in diabetis and eye treatment and who knows what else. Such an acqusition would have great potential for them in increasing their pipeline, what would they need to pay I think something around or over $3billion would do it maybe even less. We should remember that maybe the Starpharma team are getting worn out now it has been a long journey which without a big Pharma takeover still has a long way to go, a buyout accelerates the journey to end user significantly and puts huge resources into getting this science to patients. "AstraZeneca is also working on bolstering its pipeline and is looking at suitable acquisitions. In addition to acquisitions, the company is pursuing co-development deals with companies", could Starpharma be in the mix.
http://finance.yahoo.com/news/astrazeneca-stock-rising-17-whats-145902567.html
I think it is a possibility and may even be reason for milestone delay, anyway maybe I am well off the mark but it makes sense to me.

Expand

People... don't get sucked in by these 3billion takeover goobligoo... it's pure daydreaming and have been going on for years by Rick and Morty of SPL. DYOR. The stock price history and track record of this management is worth analysing, before you jump in or determine to hold on .

SPL Price at posting: 69.0¢ Sentiment: Sell Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

HLX

Helix investor makes partial takeover bid, proposing board changes

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

There are more pages in this discussion • 6 more messages in this thread...

First 2 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.8¢		Change 0.002(2.08%)		Mkt cap ! $40.90M

Open	High	Low	Value	Volume
9.7¢	9.9¢	9.7¢	$65.08K	662.7K

Buyers (Bids)

No.	Vol.	Price($)
1	36445	9.8¢

Sellers (Offers)

Price($)	Vol.	No.
9.9¢	64440	3

View Market Depth

No.	Vol.	Price($)
1	36445	0.098
1	128722	0.096
1	59000	0.095
1	100000	0.093
1	49413	0.091

Price($)	Vol.	No.
0.099	64440	3
0.100	101606	3
0.105	114641	4
0.110	51546	2
0.115	109827	3

Last trade - 16.10pm 30/08/2024 (20 minute delay)

SPL (ASX) Chart

Why not an Aztrazenica buyout, page-2

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Helix investor makes partial takeover bid, proposing board changes

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Lendlease sells off US east coast construction operations in latest global divestment push

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Why not an Aztrazenica buyout, page-2

Top Stories

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Helix investor makes partial takeover bid, proposing board changes

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Lendlease sells off US east coast construction operations in latest global divestment push

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News